BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Resverlogix Announces Voting Results From The 2017 Annual Meeting Of Shareholders

  Resverlogix shareholders approved all resolutions outlined in the Notice of Meeting and Management Information Circular dated October 30, 2017.

  December 13, 2017

   · 

  2 min read
• Biotech Beach

  ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program

  The milestone represents an important step toward stimulating the patient’s immune system to produce an unlimited supply of killer T cells that specifically target and destroy tumor cells with minimal side effects.

  December 13, 2017

   · 

  5 min read
• Policy

  Puma Biotechnology Announces Meeting of Scientific Advisory Group on Oncology in Europe to Review Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

  The Company expects to respond to the Day-180 List of Outstanding Issues by the deadline of December 22, 2017.

  December 13, 2017

   · 

  4 min read
• Avion and Acella Pharmaceuticals Provide Statement Related to Avondale Drug Pricing News

  Avion and their partner company, Acella Pharma, recently responded to the recent news surrounding the Avondale Pharma product Niacor, a prescription version of niacin.

  December 13, 2017

   · 

  2 min read